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Abstract
Background. Screening and timely treatment of gestational hyper-
glycaemia (GH) is proved to be beneficial and improves maternal and
foetal health outcomes. To understand screening practices, we
explored the knowledge and perceptions of doctors working in public
health facilities in Bangalore, India. We also studied participation fac-
tors by examining whether undergoing glucose estimation tests
affects morning sickness in pregnant women.
Design and Methods. We aimed to understand the screening prac-
tices and knowledge of doctors. A semi-structured questionnaire was
self-administered by the 50 participant doctors, selected from the sam-
pling frame comprising of all the doctors working in public health facil-
ities. We included 105 pregnant women for baseline assessment, in
whom a well-structured questionnaire was used. 
Results. We reported that gestational diabetes mellitus (GDM)
screening was done in nearly all the health centres (96%). However,
only 12% of the doctors could provide all components of GDM diagnosis
and management correctly and 46% would diagnose by using a random
blood glucose test. A majority (92%) of the doctors had poor knowledge
(68%) about the cut-off values of glucose tests. More than 80% of preg-
nant women experienced some discomfort mostly due to rapid inges-
tion glucose in short span of time.
Conclusions. Our study established that screening for GH is done in
most public health facilities. Nonetheless, knowledge of doctors on the
glucose tests and their interpretation needs improvement. Re-orienta-
tion trainings of the doctors can improve their knowledge and thereby
can efficiently screen for GH. Further, adequate planning prior to the
tests can aid successful completion of them.
Introduction
Nearly 67 milion people live with type 2 diabetes mellitus in India,
with another 30 million in the pre-diabetes group in the year 2013, and
it is projected that this number will rise to 70 million by 2025.1,2 In
addition to other reasons, gestational hyperglycaemia (GH) con-
tributes to the rising burden of diabetes.3-6 The prevalence of GH in
India varies from 3.8 to 21%.7-10 Gestational hyperglycaemia can lead
to an elevated risk of adverse pregnancy and foetal outcomes including
maternal and perinatal mortality.11 In early pregnancy, it can result in
birth defects, often affecting major organs and an increased rate of
miscarriage.12 During the second and third trimester, GH can lead to
over-nutrition and excess growth of the baby, thereby increasing the
risk of adverse outcomes during labour and delivery.13 Although GH
usually resolves following birth, both mother and child are at higher
risk of premature onset of type II diabetes.12
It is important to screen pregnant women to facilitate safe pregnan-
cy and delivery. However, there is no consensus on whether universal
or high-risk approach should be followed for screening GH. The
Canadian Diabetes Association and U.S. Preventive Services Task
Force recommend that all asymptomatic women are screened at 24-28
weeks gestation.14 However, the American College of Obstetricians
and Gynaecologists, the Society of Obstetricians and Gynaecologists of
Canada, and the U.K. National Institute for Health and Clinical
Excellence (NICE) recommend routine risk factor-based screen-
ing.15,16 Further, NICE recommends that early screening and strict con-
trol of blood glucose is essential for better health outcomes.12,17
Diabetes in Pregnancy Study Group India (DIPSI) recommends a
single step procedure of examining a venous blood sample two hours
following 75 g oral glucose load.18 Unlike the Oral Glucose Tolerance
Test (OGTT), the DIPSI guidelines don’t recommend collection of a
fasting sample. However, it is unclear whether these guidelines are
followed in primary care settings. Karnataka State provides free com-
prehensive health care and services to 64.1 million of people and
hence provides the best opportunity to study the implementation of GH
screening in primary care settings.19 According to District Level Health
Survey (DLHS IV), utilisation of government health services for com-
Significance for public health
Rising burden of hyperglycaemia in pregnancy is a cause for concern and is
associated with short and long term deleterious consequences for mother
and offspring. Hence, there is an urgent need to explore the screening prac-
tices for gestational hyperglycaemia (GH). The current study considers
patient and doctors’ perspectives regarding GH screening. The results from
our study indicate several issues during screening of gestational hypergly-
caemia in public health facilities in Bangalore, India. These included low
awareness levels among doctors, lack of standard operating procedures and
lack of adequate care and attention provided to pregnant women. Re-orien-
tation trainings of the doctors within public health facilities can improve
their knowledge and thereby can efficiently screen for GH. Further, adequate
planning and preparation of the patient prior to the tests can help ensure
successful completion of the tests. The findings of the study are comparable
with the practices of public health hospitals in India. 
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plete antenatal care (ANC) check-up in Bangalore was 59%, with 99.6%
of the pregnant women completing at least one check-up in any public
health facility in Bangalore.21,22 In a study done by Shobhana et al. in
south India, they found that patients in a low-income group spend as
much as 25% of their income for diabetes-related care in private hospi-
tals.23 Despite providing free treatment to everyone, there are limited
studies to document the screening and treatment practices in public
health hospitals.
It is reported that pregnant women in India are at 11 times increased
risk of having glucose intolerance during pregnancy compared to
Caucasian women.24,25 There is convincing evidence that Indian moth-
ers are susceptible to gestational hyperglycaemia at younger age and at
relatively lower BMI compared to the white Caucasians.26 Furthermore,
the available evidence indicates that the prevalence of GH is higher in
urban areas as compared to rural areas.4,8,18,27 With increasing propor-
tion of urban population in India and corresponding increase in preva-
lence of gestational hyperglycaemia, it is imperative to understand the
existing screening practices during pregnancy in urban areas.8,18,25,28
However, earlier studies were done either in community settings or in
hospital based settings. To our knowledge, we did not find any evidence
about the existing screening practices in the Government run primary
care settings in urban areas. Therefore, we explored the current
screening practices in public health facilities, as the inferences would
help in arriving at scalable recommendations for practice in India.
We carried out this study in the city of Bangalore, governed by
Bruhath Bangalore Mahanagara Palike (BBMP) consisting of 198
wards with population of nearly 11 million. The public health facilities
of BBMP include 6 tertiary care hospitals and 70 health centres.
Additionally, link workers carry out outreach work in the field areas.
The public health facilities in BBMP offer ANC services to nearly 50,000
women every year, mostly in maternity Homes and about half of these
women deliver in these institutions. Hence, public health facilities pro-
vide an ideal opportunity to explore the existing screening practices in
the city of Bangalore. The objectives of the study were to i) identify the
practices employed by public health facilities for the screening and
diagnosis for GH; ii) assess the knowledge level of doctors about GH
screening by glucose estimation tests; and, iii) explore whether the
procedures for glucose tolerance tests result in worsening morning
sickness. The study was done from 10th April 2014 to 14th June 2014. 
Design and MethodsGestational hyperglycaemia screening practices inpublic health facilities
The sampling frame comprised of the 70 health centres in BBMP. We
invited 70 doctors from the health centres in BBMP to participate in the
study. Fifteen doctors could not participate in the study due to their
non-availability and 5 doctors refused to participate, leaving a total of
fifty doctors who participated in the study. All doctors were asked ques-
tions about how the screening for GH is done in the health centres. The
questionnaire also sought responses on the general profile of ANC reg-
istration, number of ANC registrations done in the year 2013, trimester
in which ANC registration was done, health staff responsible for the
ANC check-up, number of GH diagnosed in the year and health staff
doing the follow-up of pregnant women (Appendix). Knowledge of doctors about gestational hypergly-caemia screening
A convenience sample of 50 doctors working in the BBMP hospitals
was employed for assessing their knowledge on GH screening. The eli-
gibility criterion was that doctor should be working in BBMP and
should be doing ANC registration in their health centres. A semi-struc-
tured questionnaire was self-administered by the doctors who volun-
teered and consented to participate in the study. We maintained confi-
dentiality by not recording the name of doctor or health centre.
Questions to assess the knowledge of GH in doctors sought were the
general understanding of doctors regarding Gestational Diabetes
Mellitus (GDM), routine tests done for assessing GH in pregnant
women in their health centres, how they manage GH during pregnancy
and post-partum period including follow-up. User associated perspectives
We conducted in-person interviews of pregnant women in a BBMP
referral hospital with a high load of ANCs and deliveries. Based on the
available information in public health facilities, the proportion of GH
was around 3-4%.8,18,21 With the hypothesised 4% of the GH in the pop-
ulation, and design effect of 1.5, the sample size required for 95% con-
fidence limits was 89.29 By assuming a refusal rate of 15% in the refer-
ence population, the sample size required was 102. Sample size calcu-
lations were done using the OpenEpi software, version 3.30 Using pur-
posive sampling, we included 105 pregnant women in the assessment.
A structured interview was administered to collect data pertaining to
their socio-economic status, pregnancy symptoms, and difficulties
faced (if any) during the glucose estimation tests (Appendix).Ethical considerations
The identity of the participants was kept anonymous and no names
or other personal identifying information were collected from the par-
ticipants. The study was reviewed and ethical approval was obtained
from Institutional Ethics Committee, Indian Institute of Public Health-
Hyderabad, (IIPH-H), Bangalore campus. Written informed consent
was obtained from all the participants (Appendix). Administrative
approval was taken from the office of the chief health officer of BBMP. Data analysis
The collected information was compiled and entered in Microsoft
excel work sheet and analysed using SPSS (statistical package of social
science, IBM Corp. Released 2011. IBM SPSS Statistics for Windows,
Version 20.0. Armonk, New York: IBM Corp). We analysed the knowl-
edge and practices about GDM among doctors by giving a score of 3 as
excellent, 2 as good, and 1 as fair. The knowledge was assessed by pro-
viding three correct choices as components of general understanding
of doctors of gestational diabetes. For example, the question on general
understanding of doctors on gestational diabetes included the following
choices: i) is present during pregnancy; ii) disappears once baby is
born; iii) may lead to permanent type 2 DM later in life; iv) is not very
serious and v) I don’t know. Each correct choice got a score of 1 point,
thereby if the doctor provides all the three correct choices would score
3 (excellent). Similarly, two correct choices got a score of 2 (good) and
at least one correct answer as fair. The scoring pattern was decided
ahead of the plan for data analysis, third author did coding and the final
scoring was cross-cheeked by the primary author. The prevalence of
GDM was calculated by dividing number of GDM cases by the total num-
ber of women registered for ANC and expressed as percentages.
ResultsGestational hyperglycaemia screening practices inpublic health facilities
In the current study, 50 out of 70 doctors of BBMP participated, with
participation rate of 71%. Antenatal care registration was done in all
the centres, and about 40% of ANC check-ups were registered in the 1st
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trimester. About 72% of the doctors did ANC themselves, while a sepa-
rate register was maintained for GH in 22% of health centres (data not
shown). Based on the reported information from the doctors, the preva-
lence of GDM in our study was less than 1% (data not shown). Also,
28% of the pregnant women with GDM came for follow-up. The number
of ANC registration done per health centre in the year 2013 was 487.
Among the health centres, 70% had laboratory facilities, which predom-
inantly carried out pregnancy confirmation test, random blood glucose
(RBG) and blood grouping (Table 1). The most common GH screening
test employed by the health centres in BBMP was RBG (46%) (Table 2).
Ninety-six per cent of centres conducted GH screening, suggesting uni-
versality. More than half of the doctors (52%) stated that screening
would be done during 16-24 weeks, ignoring the recommended gesta-
tional age of 24-28 weeks (Table 3). Knowledge of doctors about gestational hypergly-caemia screening
Twelve per cent of doctors could correctly provide the answers
regarding general understanding of GDM, while 22% could get most of
the elements (but not all components) of the disease. Additionally, 50%
of them knew how to manage GDM, 20% had knowledge on post- preg-
nancy management of GDM, and 92% had knowledge about counselling
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Table 1. Knowledge of doctors in public health facilities of
Bangalore regarding screening of gestational hyperglycaemia,
2014.
Parameter                                                              Number       %
Presence of laboratory facility                                                                             
       Yes                                                                                                35                70
       No                                                                                                  15                30
Routine tests done in the Centre                                                                        
       Pregnancy test                                                                            33                66
       RBG                                                                                               33                66
       Blood grouping                                                                           32                64
       Scanning                                                                                      12                24
       Others                                                                                          55               110
Routine tests done outside the Centre                                                             
       Hb%                                                                                              11                22
       Blood grouping                                                                            8                 16
       HIV                                                                                                 6                 12
       HbsAg                                                                                           14                28
       Ultrasound                                                                                  39                78
       Others                                                                                          32                64
Understanding of gestational diabetes                                                              
       Excellent                                                                                      6                 12
       Good                                                                                             11                22
       Fair                                                                                                31                62
       Indeterminate                                                                             2                  4
Knowledge of GDM management                                                                        
       Excellent                                                                                     25                50
       Good                                                                                             23                46
       Indeterminate                                                                             2                  4
Knowledge on post-pregnancy management of GDM                                    
       Excellent                                                                                     10                20
       Good                                                                                             40                80
Counselling of women with GDM for exercises and LSM                             
       Excellent                                                                                     43                86
       Fair                                                                                                 3                  6
       Poor                                                                                               4                  8
RBG, random blood glucose; HB%, blood haemoglobin percentage; HIV, human immunodeficiency virus;
HbsAg, hepatitis B serum antigen; GDM, gestational diabetes mellitus; LSM, lifestyle modifications.
Table 2. Diagnosis of gestational diabetes mellitus in public
health facilities by Doctors, Bangalore, 2014.
Parameter                                                              Number       %
Test done for GDM diagnosis within health facility                                        
      RBG                                                                                                23                46
      FPG                                                                                                 9                 18
      PPBG                                                                                               6                 12
      OGTT                                                                                             22                44
GDM diagnosis using FPG                                                                                     
      No                                                                                                   28                56
      Yes                                                                                                 22                44
Cut-off of FPG for GDM diagnosis                                                                       
      Good knowledge                                                                        16                32
      Poor knowledge                                                                          34                68
GDM diagnosis using RBG                                                                                     
      No                                                                                                   30                60
      Yes                                                                                                 20                40
Cut-off of RBG for GDM diagnosis                                                                      
      Good knowledge                                                                          4                  8
      Poor knowledge                                                                          46                92
GDM diagnosis known*                                                                                        
      No                                                                                                    2                  4
      Yes                                                                                                 40                96
Amount of glucose to be given*                                                                           
      100 gs                                                                                              4                  8
      50 g                                                                                                  9                 18
      75 g                                                                                                 37                74
Recommend interval to test blood glucose*                                                    
      ½ hr, 1 hr, 2 hrs                                                                            21                42
      1 hr, 2 hrs, 3 hrs                                                                          29                58
GDM, gestational diabetes; RBG, random blood glucose; FPG, fasting plasma glucose; PPBG, post pran-
dial blood glucose; OGTT, oral glucose tolerance test. *Diagnosis of GDM by Doctors using OGTT.
Table 3. Screening of gestational hyperglycaemia in public health
facilities, Bangalore, 2014.
Parameter                                                              Number       %
Proportion of centres doing GDM screening                                                   
       Yes                                                                                                48                96
       No                                                                                                   2                  4
Screening beneficiaries                                                                                         
       All pregnant women                                                                  41                82
       Only high risk                                                                              6                 12
       Only if doubtful                                                                           3                  6
Risk factors for screening                                                                                     
       Obesity                                                                                         41                82
       Type 2DM in first degree relative                                          38                76
       History of glucose intolerance                                               36                72
       Previous infant with LGS                                                         13                26
       Age >35 years                                                                             17                34
Gestational age for screening                                                                              
       16-24 wks                                                                                     26                52
       24-28 wks                                                                                      8                 16
       28-32 wks                                                                                     16                32
GDM, gestational diabetes; type 2DM, type 2 diabetes mellitus; LGS, large for gestational age.
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of women with GDM for exercises and lifestyle modifications (Table 1). 
Despite being the gold standard for diagnosis of GDM, the majority
of doctors had poor knowledge on OGTT and even for the cut-off value
of RBG and fasting plasma glucose (FPG). On the diagnosis of GDM,
only 32% of the doctors had good knowledge of cut-off values of FPG for
diagnosis of GDM (≥126 mg/dL) and 92% were not aware of the cut-off
value of RBG (≥200 mg/dL). On diagnosis of GDM using OGTT, 96% of
doctors said they used OGTT, but 42% had poor knowledge about the
recommended interval of 1hr, 2hrs and 3hrs to collect blood samples for
glucose testing (Table 2). 
About 68% of participants said that they conducted deliveries in their
health centres and do postpartum DM screening for 54% of the cases
(Table 4). Mostly, FPG was used to detect DM and it was generally done
during 6 weeks postpartum. The majority of the doctors reported that
they provided counselling to the women for risk of GDM in next preg-
nancy and also the risk of type-2 DM (Table 4).User associated perspectives 
Among the pregnant women interviewed (n=105), more than half of
them were in their 2nd trimester. A vast majority (90%) of them self-
reported as healthy and claimed they are free from any co-existing ill-
ness. Most of them (82%) resided in areas surrounding the hospital.
Less than half of the women had studied till high school and 6% were
graduates. Ninety percent of the women were housewives. Fifty-six per-
cent had a total family income of 5000-10,000 Indian national rupees
per month, while 15% had more than 15000 per month in income. 
The unwanted side effects of GH testing included nausea, vomiting,
fainting and giddiness were more common during OGTT compared to
those who were subjected to RBG or FPG. Most of the RBG or FPG tests
were uneventful with only a few experiencing fatigue, nausea, vomit-
ing, or giddiness in pregnancy. With respect to the OGTT, the results
indicated that more than 80% of women experienced some form of
uneasiness (mostly fatigue), nausea, vomiting, or giddiness during the
procedure (data not shown).
Discussion
Our study reported the prevalence of GH in public health facilities as
less than 1%. This may be an underestimate when compared to avail-
able evidence in India of 3.8 to 21%.6,31 In another study, the overall
prevalence of GDM was 12% in Bangalore.8 The variation may have
occurred due to discrepancies in protocols for screening and diagnosis.
Such underestimation can be due to several reasons. Firstly, there is
limited knowledge of GH screening among doctors and they are
unaware of performing and interpreting the test results. It is important
to stress the need of screening and create system-wide opportunities
for referring pregnant women to be tested at health facilities. Secondly,
the lack of standard protocols and lack of necessary consumables and
equipment may pose major challenges. Thirdly, many health facilities
are understaffed and the available staff have many other tasks and dis-
eases to address and therefore difficult to prioritize GH screening. All
the centres do not have a working laboratory. Among the centres, which
had a lab facility, the tests done were mainly RBG and not confirmatory
methods of GDM. It is important that screening and early detection of
hyperglycaemia is done so that it can aid in lifestyle modifications in
pregnant women and thereby reduce future risk of DM. The other rea-
sons for variation in prevalence of GH throughout the Indian subconti-
nent can be due to varied access to care and changes in risk factors in
different geographic regions.32
The knowledge about GDM among health professionals of BBMP was
relatively poor with only 12% of the doctors knowing all the components
of GDM correctly. In India, it is reported that lack of awareness among
general practitioners results in the poor quality of care.2 Responding to
similar results including the work of Seshiah and colleagues, the state
of Tamil Nadu adopted the universal screening of all pregnant women
for GDM from 2008. A milestone was achieved in 2011 with the Indian
Ministry of Health introducing free screening for GH among the five
services offered to pregnant women below the poverty line in the
National Rural Health Mission (NRHM). Our study is in conformity
with the evidence underscoring an urgent need to strengthen and
equip infrastructure in public health facilities in order to conduct and
ensure uneventful universal screening. This should include rearrange-
ment of space and personnel within the public health facilities. Many
do not meet the basic requirement of having a cot or a bed, which is
needed for drawing blood samples in the supine position. Besides, for
OGTTs in particular, women should be closely monitored to ensure that
the test is conducted properly. The RBG and FPG are the most routinely
employed tests to help detect blood glucose levels in public health facil-
ities. Most public health facilities prefer RBG or FPG as a routine
screening test for every pregnant woman and the BBMP hospitals were
no exception. However, even when RBG was used in the health centres
for screening GH, 92% of doctors had poor knowledge about the cut-off
values for the diagnosis of GDM. Nearly half of the doctors could not
define the cut-off value of FPG, OGTT, or the recommended interval for
blood testing in the OGTT for the diagnosis of GDM. 
The results of this current study also provide also two important
quality issues to minimize adverse events while performing screening
for GH. Firstly, the blood samples drawn from a pregnant woman while
in the sitting position invariably cause hypotension, which may subse-
quently trigger giddiness, fainting, nausea, and vomiting. Secondly, the
intake of 75g of glucose can rapidly result in nausea and other discom-
fort. Nausea and emesis in early pregnancy is a common phenomenon
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Table 4. Practices of health staff during post-partum counselling
in public health facilities, Bangalore, 2014.
Parameter                                                           Number           %
Proportion of deliveries conducted in health centre                                     
       No                                                                                              16                    32
       Yes                                                                                            34                    68
Post-partum DM screening                                                                                   
       No                                                                                              23                    46
       Yes                                                                                            27                    54
Test used for post-partum screening                                                                 
       RBG                                                                                            7                     14
       FPG                                                                                           18                    36
       PPBG                                                                                          9                     18
       OGTT                                                                                        10                    20
Time at which post-partum screening is done                                                 
       6 weeks post-partum                                                            23                   85.2
       Yearly post-partum                                                                 4                    14.8
Counselling on risk of GDM in next pregnancy                                                
       No                                                                                               5                     10
       Yes                                                                                            45                    90
Counselling on risk of Type2 DM                                                                         
       No                                                                                               3                      6
       Yes                                                                                            47                    94
Risk of Type 2 DM in child                                                                                     
       No                                                                                              11                    22
       Yes                                                                                            39                    78
Counselling                                                                                                               
       Diet                                                                                           40                    80
       Exercise                                                                                   41                    82
       Follow up blood sugar level                                                48                    96
DM, diabetes mellitus; Type 2 DM, type 2 diabetes mellitus; GDM, gestational diabetes; RBG, random
blood glucose; FPG, fasting plasma glucose; PPBG, post prandial blood glucose; OGTT, oral glucose tol-
erance test.
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affecting between 50% and 70% of pregnant women, but little is known
about the aetiology and possible function of this common and often
incapacitating condition. Seventy-four per cent of women reported
nausea lasting a mean of 34.6 days.33 Morning sickness occurred in
only 1.8% of women, whereas 80% reported nausea lasting all day. Only
50% of women were relieved of nausea by 14 weeks’ gestation; 90%
had relief by week 22.34 Most pregnant women experience nausea or
vomiting some time during their pregnancy, with some estimates as
high as 90%.35 In any one week of early pregnancy we found that
between 30 and 40% of women experienced nausea either all the time
or at least once a day.36 Estimates for the most severe form of nausea
and vomiting are as high as 1.5%.37 Though most pregnant women do
not have side effects from the OGTT per se, some feel nauseated,
sweaty or light-headed during the test, especially during the drawing
of blood samples or before or after they drink the glucose solution. This
poses a challenge to conduct the test. However, for various studies
involving these tests, there is no sufficient evidence on whether or not
the OGTT are triggering these side effects in pregnant women. The
current study suggests that to ensure smooth completion of the tests,
it is important to provide pregnant women with a comfortable place to
lie down. Additionally, doctors may need to allay fears of needle-pricks
during the procedure and ensure that the glucose solution is taken in
as much time as 5 minutes.
In the state of Tamil Nadu, occasions such as maternity picnics and
bangle ceremonies conducted at primary health centres are utilized for
group counselling and other educational activities on GH for pregnant
mothers.9 The screening for glucose intolerance during pregnancy is
not done routinely and probably the undiagnosed glucose intolerance
has resulted in the increased prevalence of DM in India. This is dis-
turbing, since GH has a far-reaching consequence in predisposing off-
spring to glucose intolerance. This observation was substantiated and
documented in Pima Indians.38 Hence as a policy to identify GH and its
consequences on the infant, a 75g OGTT has been recommended to all
women in the population during the third trimester of pregnancy.38
Taking care of women with GH is the first step in the primary pre-
vention of later diabetes. Additionally, one study suggests that the
cumulative risk of offspring developing type 2 DM was 30% at the age
24 yrs.39 Our study had some limitations. The response rates of the
doctors could have been better. One of the predominant reasons for
this might be reluctance to allow researchers to evaluate their knowl-
edge of medical care. Further, our study was not powered to detect and
report on the determinants of GH screening at public health facilities.
Instead, we provide information that may be used to generate hypothe-
ses and lead to additional studies. Additionally, a comprehensive
assessment of GH screening within all of the public health facilities
was beyond the scope of this study. Another limitation of the study
includes low number of pregnant participants and inability to include
all the doctors in interview. Due to the reasons stated here, generaliz-
ability of the results of the study may be somewhat limited. 
Conclusions 
Our study found that screening practices in the public health cen-
tres were not standardized, with many doctors having poor knowledge
and awareness about screening for GH. As GH is a silent disease, uni-
versal screening of pregnant women should be carried out.9,32
Continued medical education and training for health care providers
can be a useful strategy for addressing the lack of knowledge and
awareness among doctors in our study. It is important to integrate GH
screening into the existing antenatal care services package by includ-
ing glucose testing,32 and providing the support and necessary equip-
ment to carry out the tests. Though international agreement on the
clinical criteria and method of detection of GH has been elusive, the
public health facilities should engage with professional bodies to stan-
dardize and implement universal screening for GH. As a first step
toward this, deliberations should ensue toward using a 75 g OGTT
between 24-28 weeks of gestation for all women.9,28
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